echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Lancet: 170,000 people-bariatric surgery will reduce the mortality rate of obese patients by half and extend their life span by 6 years!

    Lancet: 170,000 people-bariatric surgery will reduce the mortality rate of obese patients by half and extend their life span by 6 years!

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diabetes (DM) is considered by the World Health Organization (WHO) as one of the four major non-communicable diseases.


    Diabetes (DM) is considered by the World Health Organization (WHO) as one of the four major non-communicable diseases.


    In 2019 alone, 4.


    Most patients with T2DM have metabolic abnormalities, such as obesity.


    But at present, in most countries and regions, metabolic surgery has strict indications, and less than 1% of surgical candidates can eventually undergo metabolic surgery.


    Compared with traditional medical treatment, the lancet is more effective for long-term control of T2DM.


    Changes in blood glucose levels over time after metabolic surgery and drug treatment

    Changes in blood glucose levels over time after metabolic surgery and drug treatment

    However, the effects of metabolic surgery on long-term mortality and life expectancy still need to be more strongly estimated.


    The researchers selected 16 matched cohort studies and one prospective controlled trial from the identified 1470 articles for analysis.


    Metabolic-bariatric surgery reduced the risk of death by 49.


    Among them, after diabetic patients undergoing metabolic bariatric surgery, the all-cause mortality rate was reduced by 59.


    Changes in mortality of metabolic surgery group and control group over time

    Changes in mortality of metabolic surgery group and control group over time

    The researchers pointed out that by using the results of the meta-analysis and other published data to estimate, in the global metabolic weight-loss surgery patients with and without diabetes, the use rate of metabolic weight-loss surgery increased by 1.


    Every 1.


    This shows that metabolic surgery can enable more people to reduce long-term mortality and extend life expectancy.


    references:

    Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.


    Association of metabolic--bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.